Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07027267 · ClinicalTrials.gov registry record · NA
Safety and Effectiveness of TurbAlign™ for Middle Turbinate Medialization After Functional Endoscopic Sinus Surgery
A NA study, sponsored by Spirair.
- Active
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT07027267: Active NA study, sponsored by Spirair.
NCT07027267 is a NA study that is active but no longer recruiting, run by Spirair. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07027267, a NA study, is active but no longer recruiting, sponsored by Spirair.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
A study of a bioabsorbable implant to separate the middle turbinate from the lateral nasal wall associated with nasal/sinus surgery
Primary Outcome
Rate of lateral synechia formation resulting in occlusion of the middle meatus at each turbinate (Miller Synechia Score of 2 or 3) observed at 8 weeks.
Interventions
- DEVICE Implantation of Spirair device into the middle turbinates
- DEVICE TurbAlign
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-08-04 |
| Est. Completion | 2026-07-31 |
| Phase | NA |
What the registry record for NCT07027267 still lists
NCT07027267 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Implantation of Spirair device into the middle turbinates is the first listed.
NCT07027267 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07027267 about?
NCT07027267 is a clinical study titled "Safety and Effectiveness of TurbAlign™ for Middle Turbinate Medialization After Functional Endoscopic Sinus Surgery". A study of a bioabsorbable implant to separate the middle turbinate from the lateral nasal wall associated with nasal/sinus surgery
What is the current status of trial NCT07027267?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-08-04. Estimated completion is 2026-07-31.
What interventions are being tested in trial NCT07027267?
The interventions under investigation include: Implantation of Spirair device into the middle turbinates (DEVICE), TurbAlign (DEVICE).
Who is sponsoring clinical trial NCT07027267?
This trial is sponsored by Spirair, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07027267's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI